LCTX

#3104
Lineage Cell Therapeutics, Inc.
1.5900 USD
+6.00%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
1.5750
1.5900
년간 변동
1.4200
1.9850
일일 변동
+6.00%
월간 변동
+1.27%
6달 변화
-7.40%
년간 변동율
-7.40%
이전 종가
1.5000
Open
1.5750
Bid
Ask
Low
1.5750
High
1.5900
양
240
Open full chart

Financials

Overview 성명 Statistics
Quarterly Annual
  • Market Capitalization 396.0492 M
  • Employee 77
  • Founded 1990
  • CEO N/A
  • Website www.lineagecell.com
  • Headquarter California, United States
  • FIGI BBG000G8RJY6
  • Industry Technology
총매출
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-5.96
Price to sales ratio
26.4

Lineage Cell Therapeutics Inc

Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform, Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer.

뉴스